Blood Loss and Time to Ambulation Decreased in Lumbar Interbody Fusion Patients with TXA vs Placebo
Tranexamic Acid for Blood Loss after Transforaminal Posterior Lumbar Interbody Fusion Surgery: A Double-Blind, Placebo-Controlled, Randomized Study.Biomed Res Int. 2020 Aug 14;2020:8516504
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Forty patients undergoing transforaminal lumbar interbody fusion were randomized into receiving tranexamic acid or a placebo. Outcomes of interest included blood loss, postoperative drainage volume, time to drainage removal, time to ambulation, length of hospital stay, hemoglobin (Hb) levels post-operation, and the incidence of adverse events. Results demonstrated that intraoperative blood loss wa...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE